Pfizer Ltd.
| BSE: 500680 | Sector: Health care |
| NSE: PFIZER | ISIN Code: INE182A01018 |
| BSE 00:00 | 31 Jan | 3871.85 |
-76.85 (-1.95%) |
OPEN
3922.20 |
HIGH
3968.85 |
LOW
3852.75 |
| NSE 00:00 | 31 Jan | 3869.15 |
-76.65 (-1.94%) |
OPEN
3940.00 |
HIGH
3953.95 |
LOW
3850.05 |
| OPEN | 3922.20 |
| PREVIOUS CLOSE | 3948.70 |
| VOLUME | 2635 |
| 52-Week high | 4800.00 |
| 52-Week low | 3852.75 |
| P/E | 33.60 |
| Mkt Cap.(Rs cr) | 17,714 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Pfizer Ltd. (PFIZER) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Sun Pharma.Inds. | 1035.00 | -15.90 | -1.51 | 15585.98 |
| Dr Reddy's Labs | 4324.00 | -7.45 | -0.17 | 14405.20 |
| Cipla | 1017.00 | -17.80 | -1.72 | 13091.79 |
| Lupin | 737.95 | 3.55 | 0.48 | 11771.67 |
| Aurobindo Pharma | 408.30 | -3.30 | -0.80 | 11287.14 |
| Divi's Lab. | 3317.45 | -49.90 | -1.48 | 8879.82 |
| Alkem Lab | 3009.75 | 2.35 | 0.08 | 8829.81 |
| Glenmark Pharma. | 384.25 | 13.15 | 3.54 | 8141.58 |
| Zydus Lifesci. | 430.75 | 2.85 | 0.67 | 7981.90 |
| Torrent Pharma. | 1521.45 | -26.20 | -1.69 | 6742.32 |
| Apollo Hospitals | 4255.55 | 17.25 | 0.41 | 6098.30 |
| Ipca Labs. | 850.15 | -5.20 | -0.61 | 5399.36 |
| Alembic Pharma | 538.10 | 0.80 | 0.15 | 5035.41 |
| Abbott India | 20842.40 | -125.35 | -0.60 | 4919.27 |
| Laurus Labs | 330.40 | -11.45 | -3.35 | 4707.04 |
| Gland Pharma | 1300.20 | -9.75 | -0.74 | 4400.71 |
| Granules India | 295.90 | 4.65 | 1.60 | 3238.44 |
| Glaxosmi. Pharma | 1246.70 | -11.95 | -0.95 | 3217.51 |
| Ajanta Pharma | 1208.40 | 0.50 | 0.04 | 3140.64 |
| Piramal Pharma | 104.90 | 2.95 | 2.89 | 3094.95 |
Quick Links for Pfizer:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
